Luke Bereznicki
Overview
Explore the profile of Luke Bereznicki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
223
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Serhal S, Krass I, Saini B, Bosnic-Anticevich S, Emmerton L, Bereznicki B, et al.
J Am Pharm Assoc (2003)
. 2024 Sep;
65(1):102252.
PMID: 39326844
Background: Evidence-based asthma management services have been tested in Australian community pharmacies for over 2 decades and have been well received by patients but are not retained in practice. The...
2.
Lim R, Bilton R, Dorj G, Bereznicki L, Rowett D, Ho J, et al.
Explor Res Clin Soc Pharm
. 2023 May;
10:100268.
PMID: 37151371
Background: Medicine-related problems are common in older people living in residential aged care facilities (RACFs). Recognising the significant medicine-related problems, the Australian government has announced a $345 million funding package...
3.
Kalisch Ellett L, Dorj G, Andrade A, Bilton R, Rowett D, Whitehouse J, et al.
Drug Saf
. 2023 Apr;
46(5):493-500.
PMID: 37076609
Background: Aged care residents are vulnerable to the harmful effects of medicines; however, data on the prevalence and preventability of adverse medicine events in aged care residents are scarce. Aim:...
4.
Lartey S, Lung T, Serhal S, Bereznicki L, Bereznicki B, Emmerton L, et al.
PLoS One
. 2023 Jan;
18(1):e0279748.
PMID: 36603182
Introduction: Asthma has substantial and increasing health and economic burden worldwide. This study aimed to estimate healthcare expenditure and determine the factors that increase expenditure in Australians with poorly controlled...
5.
Dorj G, Parameswaran Nair N, Bereznicki L, Kelly T, Pratt N, Kalisch-Ellett L, et al.
Drugs Aging
. 2022 Dec;
40(1):89.
PMID: 36536261
No abstract available.
6.
Dorj G, Parameswaran Nair N, Bereznicki L, Kelly T, Pratt N, Kalisch-Ellett L, et al.
Drugs Aging
. 2022 Nov;
40(1):49-58.
PMID: 36422825
Background: Residents of aged-care facilities have high rates of adverse drug events. This study aimed to identify risk factors for adverse drug events in aged-care residents. Method: This was a...
7.
Serhal S, Krass I, Emmerton L, Bereznicki B, Bereznicki L, Bosnic-Anticevich S, et al.
NPJ Prim Care Respir Med
. 2022 Nov;
32(1):53.
PMID: 36384948
Uptake and outcomes of pharmacist-initiated general practitioner (GP) referrals for patients with poorly controlled asthma were investigated. Pharmacists referred at-risk patients for GP assessment. Patients were categorized as action takers...
8.
Schmid O, Bereznicki B, Peterson G, Stankovich J, Bereznicki L
Int J Environ Res Public Health
. 2022 May;
19(9).
PMID: 35564982
This retrospective cohort study analyzed the administrative hospital records of 91,500 patients with the aim of assessing adverse drug reaction (ADR)-related hospital admission risk after discharge from ADR and non-ADR-related...
9.
Roughead E, Pratt N, Parfitt G, Rowett D, Kalisch-Ellett L, Bereznicki L, et al.
Age Ageing
. 2022 Apr;
51(4).
PMID: 35460410
Objective: To assess the effectiveness of a pharmacist-led intervention using validated tools to reduce medicine-induced deterioration and adverse reactions. Design And Setting: Multicenter, open-label parallel randomised controlled trial involving 39...
10.
Serhal S, Armour C, Billot L, Krass I, Emmerton L, Saini B, et al.
Front Pharmacol
. 2022 Apr;
13:869162.
PMID: 35401235
Accurate clinical assessment of patient adherence using reliable and valid measures is essential in establishing the presence of adherence issues and support practices for pharmacists. This investigation aims to conduct...